Nimodipine for treatment of idiopathic epilepsy in dogs

Journal of the American Veterinary Medical Association

Volumn 210, Issue 9, 1997, Pages 1298-1301

  O'Brien, Dennis P ^a   Simpson, Stephen T ^b   Longshore, Randall C ^a,d   Kroll, Robert A ^a,e   Goetze, Leopold ^c  

^a UNIVERSITY OF MISSOURI   (United States)

^b AUBURN UNIVERSITY   (United States)

^c BAYER AG   (Germany)

^d Veterinary Neurological Center   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NIMODIPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; FEMALE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 0030890898     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Farnbach GC. Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy. J Am Vet Med Assoc 1984;184:1117-1120.
2. Schwartz-Porsche D, Loscher W, Frey HH. Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparison. J Vet Pharmacol Ther 1985;8:113-119.
3. Schwartz-Porsche D. Management of refractory epilepsy. In: Kirk RW, Bonagura JD, eds. Current veterinary therapy XI. Philadelphia: WB Saunders Co, 1992;986-991.
4. Frey HH, Loscher W. Pharmacokinetics of anti-epileptic drugs in the dog: a review. J Vet Pharmacol Ther 1985;8:219-233.
5. Bunch SE, Castleman WL, Hornbuckle WE, et al. Hepatic cirrhosis associated with long-term anticonvulsant drug therapy in dogs. J Am Vet Med Assoc 1982;181:357-362.
6. Dayrell-Hart B, Steinberg SA, VanWinkle TJ, et al. Hepatotoxicity of phenobarbital in dogs: 18 cases (1985-1989). J Am Vet Med Assoc 1991;199:1060-1066.
7. Yohn SE, Morrison WB, Sharp PE. Bromide toxicosis (bromism) in a dog treated with potassium bromide for refractory seizures. J Am Vet Med Assoc 1992;201:468-470.
8. Adler EM, Selzer ME. Cellular pathophysiology and pharmacology of epilepsy. In: Asbury AK, McKhann GM, McDonald Wl, eds. Diseases of the nervous system. Philadelphia: WB Saunders Co, 1986;982-999.
9. Brandt L, Saveland H, Ljunggren B, et al. Control of epilepsy partialis continuans with intravenous nimodipine. J Neurosurg 1988;69:949-950.
10. Greenberg DA. Calcium channels and calcium channel antagonists. Ann Neurol 1987;21:317-330.
11. Pelliccia A, Sciaretta A, Matricardi M. Nimodipine treatment for drug-resistant childhood epilepsy. Dev Med Child Neurol 1990;32:1114-1115.
12. Popoli P, Pezzola A, Scotti de Carlos A. Effects of calcium antagonist nimodipine on pentylenetetrazole-induced seizures in rats and rabbits. Arch Int Pharmacodyn Ther 1988;292:58-67.
13. Morocutti C, Pierelli F, Sanarelli L, et al. Antiepileptic effects of a calcium antagonist (nimodipine) on cefazolin-induced epileptogenic foci in rabbits. Epilepsia 1986;27:498-503.
14. Dolin SJ, Hunter AB, Halsey MJ, et al. Anticonvulsant profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine. Eur J Pharmacol 1988;152:19-27.
15. Thomas J. The effect of nimodipine on picrotoxin-induced seizures. Brain Res Bull 1990;24:11-15.
16. O'Neill SK, Bolger GT. The effects of dihydropyridine calcium channel modulators on pentylenetetrazole convulsions. Brain Res Bull 1990;25:211-214.
17. De Sarro G, De Sarro A, Federico F, et al. Anticonvulsant properties of some calcium antagonists on sound-induced seizures in genetically prone rats. Gen Pharmacol 1990;21:769-778.
18. Kamal JA, Nadig RS, Joseph T, et al. Effect of calcium channel blockers on experimentally induced seizures in rats. Indian J Exp Biol 1990;28:605-608.
19. + antagonist. Epilepsia 1987;28:409-414.
20. Ots ME, Yaksh TL, Anderson RE, et al. Effect of dihydropyridines and diphenylalkylamines on pentylenetetrazole-induced seizures and cerebral blood flow in cats. J Neurosurg 1987;67:406-413.
21. 2+ antagonists in electrocortical shock seizures. Epilepsia 1990;31:68-74.
22. 2+ channel antagonist nimodipine on kainic acid induced limbic seizures. Epilepsy Res 1990;6:33-38.
23. de Falco FA, Bartiromo U, Majello L, et al. Calcium antagonist nimodipine in intractable epilepsy. Epilepsia 1992;33:343-345.
24. Larkin JG, McKee PJ, Blacklaw J, et al. Nimodipine in refractory epilepsy: a placebo-controlled, add-on study. Epilepsy Res 1991;9:71-77.
25. Meyer FB, Cascino GD, Whisnant JP, et al. Nimodipine as an add-on therapy for intractable epilepsy. Mayo Clin Proc 1995;70:623-627.
26. Mueck W, Bode H. Bioanalytics of nimodipine: an overview of methods. Pharmazie 1994;49:130-139.
27. Podell M. The use of diazepam per rectum at home for the acute management of cluster seizures in dogs. J Vet Intern Med 1995;9:68-74.
28. Schluter G. Toxicological investigations with nimodipine. Summary of relevant studies. Arzneimittelforschung 1986;36:1733-1735.
29. O'Grady MR. Acquired valvular heart disease. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. Philadelphia: WB Saunders Co, 1995;944-959.
30. Ramsch KD, Ahr G, Tettenborn D, et al. Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage. Neurochirurgie 1985;28:74-78.
31. Allen GS, Ahn HS, Prziosi TJ, et al. Cerebral arterial spasm - a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983;308:619-624.
32. Scherling D, Buhner K, Krause HP, et al. Biotransformation of nimodipine in rat, dog, and monkey. Arzneimittelforschung 1991;41:392-398.
33. Tartara A, Galimberti CA, Manni R, et al. Different effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients. Br J Clin Pharmacal 1991;32:335-340.
34. Ravis WR, Pedersoli WM, Wike JS. Pharmacokinetics of phenobarbital in dogs given multiple doses. Am J Vet Res 1989;50:1343-1347.